FSGEX
Price
$20.81
Change
+$0.01 (+0.05%)
Updated
Jul 31 closing price
Net Assets
74.78B
JSEAX
Price
$23.59
Change
-$0.15 (-0.63%)
Updated
Jul 31 closing price
Net Assets
5.08B
Interact to see
Advertisement

FSGEX vs JSEAX

FSGEX vs JSEAX Comparison Chart in %
View a ticker or compare two or three
VS
FSGEX vs. JSEAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGEX is a Hold and JSEAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 74.8B vs. JSEAX (5.08B). FSGEX pays higher dividends than JSEAX: FSGEX (2.66) vs JSEAX (2.37). FSGEX was incepted earlier than JSEAX: FSGEX (17 years) vs JSEAX (24 years). JSEAX (1.11) is less costly to investors than FSGEX (0.01). JSEAX is a more actively managed with annual turnover of: 44.00 vs. FSGEX (8.00). FSGEX has a lower initial minimum investment than JSEAX: FSGEX (0) vs JSEAX (1000). FSGEX annual gain was more profitable for investors over the last year : 28.80 vs. JSEAX (14.22). FSGEX return over 5 years is better than : 55.46 vs. JSEAX (21.40).
FSGEXJSEAXFSGEX / JSEAX
Total Expense Ratio0.010.951%
Annual Report Gross Expense Ratio0.011.111%
Fund Existence17 years24 years-
Gain YTD13.7169.721141%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets74.8B5.08B1,472%
Annual Yield % from dividends2.662.37112%
Returns for 1 year28.8014.22203%
Returns for 3 years63.2239.94158%
Returns for 5 years55.4621.40259%
Returns for 10 years135.0598.03138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUCX20.370.29
+1.44%
NYLI PineStone U.S. Equity Class C
MAILX24.190.17
+0.71%
BlackRock International Instl
MMMMX56.82-0.14
-0.25%
Victory Integrity Discovery Member
PDGIX89.88-0.39
-0.43%
T. Rowe Price Dividend Growth I
MGHRX63.84-1.31
-2.01%
Morgan Stanley Inst Growth IR